Aprindine Hydrochloride

盐酸阿普林定

Report date: 2025/10/09 16:59:36
NME

Base Information

Drug NameAprindine Hydrochloride
Drug Alias Nameaprindinum盐酸阿普林定aprindina盐酸茚丙胺茚满丙二胺盐酸盐 +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type V alpha subunit blockersCalmodulin antagonists
TargetsSodium channel protein type V alpha subunitCalmodulin
Therapy Area/IndicationsTachycardiaArrhythmias, Cardiac
Global Approved IndicationsTachycardiaArrhythmias, Cardiac
Approved Indications in ChinaArrhythmias, Cardiac
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGTipr Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTachycardiaArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeC01BB04
Related LinksWikipediaDrugBankKEGG